American International Group, Inc. Celularity Inc Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $341 - $701	610 Added 2.03%	30,639 $18,000
Q4 2022 Feb 10, 2023	SELL	$1.08 - $2.35 $2,107 - $4,584	-1,951 Reduced 6.1%	30,029 $38,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $10,615 - $106,400	24,687 Added 338.5%	31,980 $74,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $20,493 - $94,152	7,293 New	7,293 $25,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $313M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.